CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 203-210

  Haile, Lydia A ^a,b   Gamrekelashvili, Jaba ^a,b   Manns, Michael P ^a   Korangy, Firouzeh ^a,b   Greten, Tim F ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BIOLOGICAL MARKER; CD11B ANTIGEN; CHEMOKINE RECEPTOR; EPITOPE; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; ENTERITIS; FEMALE; GENE EXPRESSION; GRANULOCYTE; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUMOR; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COLORECTAL TUMOR; COMPARATIVE STUDY; EXPERIMENTAL NEOPLASM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD11B; BIOLOGICAL MARKERS; CELLS, CULTURED; COLORECTAL NEOPLASMS; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INFLAMMATORY BOWEL DISEASES; INTEGRIN ALPHA4; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; RECEPTORS, CHEMOKINE; T-LYMPHOCYTE SUBSETS;

EID: 77956205298     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903573     Document Type: Article

References (21)

1. Serafini, P., I. Borrello, and V. Bronte. 2006. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin. Cancer Biol. 16: 53-65.
2. Marigo, I., L. Dolcetti, P. Serafini, P. Zanovello, and V. Bronte. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222: 162-179.
3. Haile, L. A., R. von Wasielewski, J. Gamrekelashvili, C. Kruger, O. Bachmann, A. M. Westendorf, J. Buer, R. Liblau, M. P. Manns, F. Korangy, and T. F. Greten. 2008. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway. Gastroenterology 135: 871-881, 881.e1-5.
4. Movahedi, K., M. Guilliams, J. Van den Bossche, R. Van den Bergh, C. Gysemans, A. Beschin, P. De Baetselier, and J. A. Van Ginderachter. 2008. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T-cell suppressive activity. Blood 111: 4233-4244.
5. Youn, J. I., S. Nagaraj, M. Collazo, and D. I. Gabrilovich. 2008. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
6. Yang, R., Z. Cai, Y. Zhang, W. H. Yutzy, 4th, K. F. Roby, and R. B. Roden. 2006. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res. 66: 6807-6815.
7. Huang, B., P. Y. Pan, Q. Li, A. I. Sato, D. E. Levy, J. Bromberg, C. M. Divino, and S. H. Chen. 2006. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res. 66: 1123-1131.
8. Gallina, G., L. Dolcetti, P. Serafini, C. De Santo, I. Marigo, M. P. Colombo, G. Basso, F. Brombacher, I. Borrello, P. Zanovello, et al. 2006. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116: 2777-2790.
9. González-Amaro, R., M. Mittelbrunn, and F. Sánchez-Madrid. 2005. Therapeutic anti-integrin (alpha4 and alphaL) monoclonal antibodies: two-edged swords? Immunology 116: 289-296.
10. Hoechst, B., T. Voigtlaender, L. Ormandy, J. Gamrekelashvili, F. Zhao, H. Wedemeyer, F. Lehner, M. P. Manns, T. F. Greten, and F. Korangy. 2009. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50: 799-807.
11. Westendorf, A. M., D. Fleissner, S. Deppenmeier, A. D. Gruber, D. Bruder, W. Hansen, R. Liblau, and J. Buer. 2006. Autoimmune-mediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 131: 510-524.
12. Morgan, D. J., R. Liblau, B. Scott, S. Fleck, H. O. McDevitt, N. Sarvetnick, D. Lo, and L. A. Sherman. 1996. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157: 978-983.
13. Sinha, P., V. K. Clements, and S. Ostrand-Rosenberg. 2005. Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174: 636-645. (Pubitemid 40094255)
14. Nefedova, Y., M. Fishman, S. Sherman, X. Wang, A. A. Beg, and D. I. Gabrilovich. 2007. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Res. 67: 11021-11028.
15. Finn, O. J. 2008. Cancer immunology. N. Engl. J. Med. 358: 2704-2715.
16. Cho, J. H. 2008. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. 8: 458-466.
17. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Natl. Rev. Immunol. 9: 162-174.
18. Greifenberg, V., E. Ribechini, S. Rössner, and M. B. Lutz. 2009. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 39: 2865-2876.
19. Elghetany, M. T. 2002. Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis. 28: 260-274.
20. Issekutz, T. B., M. Miyasaka, and A. C. Issekutz. 1996. Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J. Exp. Med. 183: 2175-2184.
21. Kubes, P., X. F. Niu, C. W. Smith, M. E. Kehrli, Jr., P. H. Reinhardt, and R. C. Woodman. 1995. A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J. 9: 1103-1111.